Literature DB >> 15149867

Disseminated intravascular coagulation.

Hideo Wada1.   

Abstract

The diagnosis of disseminated intravascular coagulation (DIC) was initially based on the detection of microthrombi. Current diagnosis involves laboratory assessment of hemostatic abnormalities although additional studies may often be necessary. DIC is characterized by hypercoagulability and hyperfibrinolysis and is caused by high offense factors or low defense factors. DIC is divided two stages: overt-DIC and non-overt-DIC. The diagnosis of overt-DIC state is based on the criteria developed by the International Society of Thrombosis Haemostasis in conjunction with the Japanese Ministry Health and Welfare. However, no criteria are currently available for the diagnosis of non-overt DIC. Although scientifically supported modalities for treatment of DIC are few, the use of activated protein C (APC) and low-molecular-weight heparin appear to hold promise. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149867     DOI: 10.1016/j.cccn.2004.02.015

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

2.  The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.

Authors:  Takumi Aota; Hideo Wada; Yoshiki Yamashita; Takeshi Matsumoto; Kohshi Ohishi; Kei Suzuki; Hiroshi Imai; Masanobu Usui; Shuji Isaji; Naoyuki Katayama
Journal:  Int J Hematol       Date:  2015-11-21       Impact factor: 2.490

Review 3.  Thrombosis in COVID-19.

Authors:  Thomas C Hanff; Amir M Mohareb; Jay Giri; Jordana B Cohen; Julio A Chirinos
Journal:  Am J Hematol       Date:  2020-09-16       Impact factor: 10.047

Review 4.  Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.

Authors:  Arturo J Martí-Carvajal; Gabriella Comunián-Carrasco; Guiomar E Peña-Martí
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

5.  Thrombocytopenia in the experimental leptospirosis of guinea pig is not related to disseminated intravascular coagulation.

Authors:  Hong-Liang Yang; Xu-Cheng Jiang; Xiang-Yan Zhang; Wen-Jun Li; Bao-Yu Hu; Guo-Ping Zhao; Xiao-Kui Guo
Journal:  BMC Infect Dis       Date:  2006-02-02       Impact factor: 3.090

Review 6.  Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines.

Authors:  Hideo Wada; Takeshi Matsumoto; Yoshiki Yamashita
Journal:  J Intensive Care       Date:  2014-02-20

7.  Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.

Authors:  Guo Chen; Jian-Qing He
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Authors:  Gerhardus J A J M Kuiper; Marie-Claire F Kleinegris; René van Oerle; Henri M H Spronk; Marcus D Lancé; Hugo Ten Cate; Yvonne M C Henskens
Journal:  Thromb J       Date:  2016-01-14

Review 9.  Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.

Authors:  Hideo Wada; Takeshi Matsumoto; Kei Suzuki; Hiroshi Imai; Naoyuki Katayama; Toshiaki Iba; Masanori Matsumoto
Journal:  Thromb J       Date:  2018-07-11

10.  Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.

Authors:  Takuhiro Yamaguchi; Yukio Kitajima; Yasuhiro Miyauchi; Kazutoshi Izawa; Masakazu Tanaka; Masatada Hirata; Yasunari Sadatsuki; Yoshihiro Ogawa
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.